Beta Bionics announced a partnership with Senseonics to integrate the Eversense 365 continuous glucose monitor with its iLet and future mint AID systems. The integration, launching in Q4 2026, will make iLet compatible with more CGM manufacturers than any other AID system. Despite the strategic partnership, BBNX shares fell over 8% following the announcement.
SENS
Senseonics Holdings, Inc. · NASDAQ
News
1 latestNo direct coverage yet · Showing articles that mention SENS
Headlines link to the publisher. Not investment advice.
Analysts
All ›Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.
Community
7 daysNo sentiment yet
Posts 24h
0
Replies 24h
0
Watchers
0
Board · $SENS · 0 threads
Sign in to post on $SENS
No threads yet
Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.